Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ltd Bioventures Novartis

Affiliations

  • Large Shareholder at Bicycle Therapeutics Plc (BCYC), 2019-05-31
  • Large Shareholder at Aerpio Pharmaceuticals Inc. (ARPO), 2019-04-29
  • Large Shareholder at Aileron Therapeutics Inc (ALRN), 2019-04-03
  • Large Shareholder at Altimmune Inc. (ALT), 2018-10-04
  • at Aeglea Biotherapeutics Inc. (AGLE), 2018-05-14
  • Large Shareholder at Ra Pharmaceuticals Inc. (RARX), 2017-06-20
  • Large Shareholder at Proteostasis Therapeutics Inc. (PTI), 2016-02-17
  • Large Shareholder at Tokai Pharmaceuticals Inc (TKAI), 2015-07-17
  • Large Shareholder at Akebia Therapeutics Inc. (AKBA), 2014-03-27
  • Large Shareholder at Celladon Corp (CLDN), 2014-02-06
  • Large Shareholder at Marina Biotech Inc. (MRNA), 2011-01-27
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
BCYC $14.00 168,630 Large Shareholder 1,769,641 2019-05-28 Filing
ALRN $15.00 266,667 Large Shareholder 2,544,182 2017-07-05 Filing
NONE $5.00 560,000 Large Shareholder 5,805,550 2017-03-15 Filing
RARX $13.00 84,615 Large Shareholder 2,545,652 2016-10-31 Filing
AGLE $10.00 300,000 Large Shareholder 2,310,924 2016-04-12 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ARPO $1.03 138,704 Large Shareholder 4,049,804 2019-04-26 Filing
ARPO $1.03 563,096 Large Shareholder 4,188,508 2019-04-25 Filing
ARPO $1.03 16,403 Large Shareholder 4,751,604 2019-04-24 Filing
ARPO $1.03 27,554 Large Shareholder 4,768,007 2019-04-23 Filing
ARPO $0.97 7,100 Large Shareholder 4,795,561 2019-04-22 Filing